Microstructural alterations of sputum in cystic fibrosis lung disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  JCI Insight

• Publication date

  2016-11-07

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1172/jci.insight.88198PMID 27812540PMCID PMC5085601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Particle tracking in drug and gene delivery research: State-of-the-art applications and methods.

  2015influential reference
• The Relationship of Mucus Concentration (Hydration) to Mucus Osmotic Pressure and Transport in Chronic Bronchitis.

  2015cited by this paper
• Oxidation increases mucin polymer cross-links to stiffen airway mucus gels

  2015influential reference
• Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure.

  2014cited by this paper
• Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors.

  2014influential reference
• Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis

  2014cited by this paper
• A Biophysical Basis for Mucus Solids Concentration as a Candidate Biomarker for Airways Disease

  2014cited by this paper
• Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers.

  2013cited by this paper
• Nanoparticle diffusion in respiratory mucus from humans without lung disease.

  2013influential reference
• Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health.

  2013cited by this paper
• A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia

  2012influential reference
• Reduced Airway Surface pH Impairs Bacterial Killing in the Porcine Cystic Fibrosis Lung

  2012cited by this paper
• Treatment of lung infection in patients with cystic fibrosis: current and future strategies.

  2012cited by this paper
• Mucus Penetrating Nanoparticles: Biophysical Tool and Method of Drug and Gene Delivery

  2012cited by this paper
• Airway mucus function and dysfunction.

  2011cited by this paper
• Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine.

  2011cited by this paper
• Hyaluronic Acid Hydrogels for Biomedical Applications

  2011cited by this paper
• Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis

  2011cited by this paper
• Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.

  2011cited by this paper
• N-acetylcysteine Enhances Cystic Fibrosis Sputum Penetration and Airway Gene Transfer by Highly Compacted DNA Nanoparticles.

  2011cited by this paper
• Synthesis and characterization of in situ cross-linked hydrogel based on self-assembly of thiol-modified chitosan with PEG diacrylate using Michael type addition

  2010cited by this paper
• Airway mucus function and dysfunction.

  2010cited by this paper
• Cystic Fibrosis

  2009cited by this paper
• The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles.

  2009influential reference
• Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses

  2009cited by this paper
• Mucus, Phlegm, and Sputum in Cystic Fibrosis

  2009cited by this paper
• Ex vivo sputum analysis reveals impairment of protease-dependent mucus degradation by plasma proteins in acute asthma.

  2009cited by this paper
• Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum

  2009cited by this paper
• Monitoring Respiratory Disease Severity in Cystic Fibrosis

  2009cited by this paper
• Barrier properties of mucus.

  2009cited by this paper
• Airway inflammation in cystic fibrosis.

  2008cited by this paper
• Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis

  2008cited by this paper
• Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

  2007cited by this paper
• Pulmonary exacerbations in cystic fibrosis and bronchiectasis

  2007cited by this paper
• Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

  2007cited by this paper
• Airway surface dehydration in cystic fibrosis: pathogenesis and therapy.

  2007cited by this paper
• A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms

  2006cited by this paper
• Mucus in chronic airway diseases: sorting out the sticky details.

  2006cited by this paper
• Effective mucus clearance is essential for respiratory health.

  2006cited by this paper
• Reduced Three-Dimensional Motility in Dehydrated Airway Mucus Prevents Neutrophil Capture and Killing Bacteria on Airway Epithelial Surfaces1

  2005cited by this paper
• Cystic fibrosis.

  2005cited by this paper
• In situ crosslinkable hyaluronan hydrogels for tissue engineering.

  2004cited by this paper
• Pathophysiology and management of pulmonary infections in cystic fibrosis.

  2003cited by this paper
• Enhanced Viscoelasticity of Human Cystic Fibrotic Sputum Correlates with Increasing Microheterogeneity in Particle Transport*

  2003cited by this paper
• Mucociliary clearance in cystic fibrosis

  2002cited by this paper
• Mucus clearance as a primary innate defense mechanism for mammalian airways.

  2002cited by this paper
• Physiology of airway mucus clearance.

  2002influential reference
• Cystic fibrosis sputum: a barrier to the transport of nanospheres.

  2000cited by this paper
• Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage.

  1998cited by this paper
• Methods of Digital Video Microscopy for Colloidal Studies

  1996cited by this paper
• Distribution of DNA and alginate in purulent cystic fibrosis sputum: implications to pulmonary targeting strategies.

  1996cited by this paper
• Surface properties of respiratory secretions: Relationship with mucus transport

  1995influential reference
• Optical measurements of frequency-dependent linear viscoelastic moduli of complex fluids.

  1995cited by this paper
• The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum.

  1990cited by this paper
• Scaling Concepts in Polymer Physics

  1979cited by this paper
• Mucociliary clearance in cystic fibrosis.

  1976cited by this paper
• PRINCIPLES OF MEDICAL STATISTICS

  1948cited by this paper

• Microrheology of gel-forming airway mucins isolated from porcine trachea

  2025cites this paper
• Analytic Approaches to Physicochemical Properties of Materials for Biomedical Applications Across Nanoscopic and Macroscopic Length Scales.

  2025cites this paper
• Mucus Physically Restricts Influenza A Viral Particle Access to the Epithelium

  2025cites this paper
• Myeloperoxidase impairs mucociliary transport on human airway epithelium

  2025cites this paper
• Lung tissue-optimized gene editing in human cystic fibrosis models following topical application of lipid nanoparticles.

  2025cites this paper
• Scalable Extraction of Airway Mucins from Porcine Trachea

  2024cites this paper
• Synthetic mucus biomaterials synergize with antibiofilm agents to combat Pseudomonas aeruginosa biofilms

  2024cites this paper
• In situ pulmonary mucus hydration assay using rotational and translational diffusion of gold nanorods with polarization-sensitive optical coherence tomography

  2024cites this paper
• Synthetic mucus barrier arrays as a nanoparticle formulation screening platform

  2024cites this paper
• Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases

  2024cites this paper
• Exploring Mechanisms of Lipid Nanoparticle-Mucus Interactions in Healthy and Cystic Fibrosis Conditions

  2024cites this paper
• Comprehensive Characterization of the Viscoelastic Properties of Bovine Submaxillary Mucin (BSM) Hydrogels and the Effect of Additives

  2024cites this paper
• Mucoadhesion across scales: Towards the design of protein-based adhesives.

  2024cites this paper
• Sputum handling for rheology

  2023cites this paper
• Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers.

  2023cites this paper
• Advances in nanomaterial-based targeted drug delivery systems

  2023cites this paper
• Synthetic mucus barrier arrays as a nanoparticle formulation screening platform

  2023cites this paper
• Inhaled RNA drugs to treat lung diseases: Disease-related cells and nano-bio interactions.

  2023cites this paper
• Nanotechnology-Based Drug Delivery Systems to Control Bacterial-Biofilm-Associated Lung Infections

  2023cites this paper
• Engineering in vitro models of cystic fibrosis lung disease using neutrophil extracellular trap inspired biomaterials.

  2023cites this paper
• Barriers for orally inhaled therapeutic antibodies

  2023cites this paper
• Mucus physically restricts influenza A viral particle access to the epithelium

  2023cites this paper
• Engineering in vitro models of cystic fibrosis lung disease using neutrophil extracellular trap inspired biomaterials

  2023cites this paper
• Physiology and Pathophysiology of Human Airway Mucus.

  2022cites this paper
• Unconventionally fast transport through sliding dynamics of rodlike particles in macromolecular networks

  2022cites this paper
• High-Density Branched PEGylation for Nanoparticle Drug Delivery

  2022cites this paper
• Mucus-Inspired Dynamic Hydrogels: Synthesis and Future Perspectives

  2022cites this paper
• Biochemical, biophysical, and immunological characterization of respiratory secretions in severe SARS-CoV-2 infections.

  2022cites this paper
• From Static to Dynamic: A Review on the Role of Mucus Heterogeneity in Particle and Microbial Transport.

  2022cites this paper
• Mucus and mucus flake composition and abundance reflect inflammatory and infection status in cystic fibrosis.

  2022cites this paper
• Biochemical, Biophysical, and Immunological Characterization of Respiratory Secretions in Severe SARS-CoV-2 (COVID-19) Infections

  2022cites this paper
• Alginate oligosaccharides enhance diffusion and activity of colistin in a mucin-rich environment

  2022cites this paper
• Female reproductive fluid composition differs based on mating system in Peromyscus mice

  2022cites this paper
• MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium

  2022influential citation
• Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach

  2022cites this paper
• Machine learning-informed predictions of nanoparticle mobility and fate in the mucus barrier

  2022influential citation
• Generating an In Vitro Gut Model with Physiologically Relevant Biophysical Mucus Properties

  2022cites this paper
• Models using native tracheobronchial mucus in the context of pulmonary drug delivery research: Composition, structure and barrier properties.

  2022cites this paper
• Combination and nanotechnology based pharmaceutical strategies for combating respiratory bacterial biofilm infections.

  2022cites this paper
• Therapeutic antibodies – natural and pathological barriers and strategies to overcome them

  2021cites this paper
• Membrane-Tethered Mucin 1 is Stimulated by Interferon in Multiple Cell Types and Antagonizes Influenza A Virus Infection in Human Airway Epithelium

  2021cites this paper
• Nanofibrillar Hydrogel Recapitulates Changes Occurring in the Fibrotic Extracellular Matrix.

  2021cites this paper
• The Delivery Challenge of Genome Editing in Human Epithelia

  2021cites this paper
• Shaping nanoparticle diffusion through biological barriers to drug delivery

  2021cites this paper
• Combined use of rheology and portable low-field NMR in cystic fibrosis patients.

  2021cites this paper
• Disulfide disruption reverses mucus dysfunction in allergic airway disease

  2021cites this paper
• Forgotten but not gone: Particulate matter as contaminations of mucosal systems.

  2021cites this paper
• Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung

  2020cites this paper
• Neutrophil Extracellular Traps Increase Airway Mucus Viscoelasticity and Slow Mucus Particle Transit.

  2020cites this paper
• Mucin Biopolymers and Their Barrier Function at Airway Surfaces.

  2020cites this paper
• Modeling airway dysfunction in asthma using synthetic mucus biomaterials

  2020cites this paper
• Rheological analysis of sputum from patients with chronic bronchial diseases

  2020cites this paper
• Hyaluronan is abundant in COVID-19 respiratory secretions

  2020cites this paper
• Influenza A virus diffusion through mucus gel networks

  2020influential citation
• Plate reader microrheology

  2020cites this paper
• Dry powder aerosol containing muco-inert particles for excipient enhanced growth pulmonary drug delivery.

  2020cites this paper
• Current Status and Perspectives in Mucosal Drug Delivery of Nanotherapeutic Systems

  2020cites this paper
• Validation of hyaluronic acid-agar-based hydrogels as vitreous humor mimetics for in vitro drug and particle migration evaluations.

  2020cites this paper
• The Effects of the Anti-aging Protein Klotho on Mucociliary Clearance

  2020cites this paper
• Leveraging 3D Model Systems to Understand Viral Interactions with the Respiratory Mucosa

  2020influential citation
• Widespread gene transfer to malignant gliomas with In vitro-to-In vivo correlation.

  2019cites this paper
• Understanding the collective dynamics of motile cilia in human airways

  2019cites this paper
• Safety, Tolerability, and Effects of Sodium Bicarbonate Inhalation in Cystic Fibrosis

  2019cites this paper
• A rational approach to form disulfide linked mucin hydrogels.

  2019cites this paper
• Disulfide disruption reverses mucus dysfunction in allergic airway disease

  2019cites this paper
• Reliably Sourced Airway Mucus.

  2019cites this paper
• Tolerogenic cargo delivery via polymeric microparticles in reducing autoimmune-specific inflammation

  2019cites this paper
• A combinatorial biomolecular strategy to identify peptides for improved transport across the sputum of cystic fibrosis patients and the underlying epithelia

  2019influential citation
• Endotracheal Tube Mucus as a Source of Airway Mucus for Rheological Study.

  2019influential citation
• Designing viscoelastic mucin-based hydrogels

  2019cites this paper
• Nanoparticle diffusion in spontaneously expectorated sputum as a biophysical tool to probe disease severity in COPD

  2019cites this paper
• Cystic Fibrosis Sputum Rheology Correlates With Both Acute and Longitudinal Changes in Lung Function

  2018cites this paper
• Seeing cilia: imaging modalities for ciliary motion and clinical connections.

  2018cites this paper
• Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice

  2018cites this paper
• Evidence that self-similar microrheology of highly entangled polymeric solutions scales robustly with, and is tunable by, polymer concentration.

  2018cites this paper
• Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH

  2018cites this paper
• An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene Therapy

  2018influential citation
• Engineering the Mucus Barrier.

  2018cites this paper
• Co association of mucus modulating agents and nanoparticles for mucosal drug delivery☆

  2018cites this paper
• Gel-forming mucin interactome drives mucus viscoelasticity.

  2017cites this paper
• Mucins, Mucus, and Goblet Cells

  2017cites this paper
• Technological strategies to estimate and control diffusive passage times through the mucus barrier in mucosal drug delivery☆

  2017cites this paper
• Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation

  2017cites this paper
• The Mucus Barrier to Inhaled Gene Therapy.

  2016cites this paper
• B I O M E D I C a L E N G I N E E R I N G

  year unknowncites this paper